Advance Care Planning in Complex Stage Parkinson’s Disease
Objective: Advance Care Planning (ACP) in patients with Complex stage Parkinson’s disease (PD) at the Royal Berkshire Foundation Trust (RBFT),Reading,United Kingdom. Background: In April 2019,…Patient survey on personal preferences and choices regarding Advance Care Planning(ACP) in Parkinson’s Disease(PD)
Objective: Understanding patients' choices and preferences in the advanced stage Parkinson’s disease. Background: Surveys of patients' experiences are increasingly recognized as an essential part of…Creating moments that matter – A person-centered approach for the geriatric patient at the Parkinson Unit at Vrinnevi Hospital, Norrköping, Sweden
Objective: To encourage patients to prepare for a routine visit to the nurse, in order to obtain a more person-centered care and an opportunity to…Does age at onset of Parkinson’s disease affect the development of dementia?
Objective: To investigate whether progression to dementia in senile Parkinson’s disease, SPD, (disease onset after 70 years) differs from that in old Parkinson’s disease, OPD,…Contribution of coding/noncoding variants in NUS1 to late-onset sporadic Parkinson’s disease
Objective: Here, we designed a case-control study to analyze WGS variants in NUS1 coding regions and NUS1 related non-coding regions to investigate the relative contribution…NUS1 polymorphisms modify the risk and age at onset of Parkinson’s disease
Objective: In this study, using whole-exome sequencing (WES) and direct Sanger sequencing analysis, we investigated the common and low-frequency variants of NUS1 in two case-control…Survival in Parkinson’s Disease and Association with MAPT and APOE
Objective: To assess survival in a large cohort of Parkinson's disease (PD) patients, and to determine if survival correlates with MAPT and APOE gene variants.…The feasibility of detailed phenotyping of muscle mitochondrial respiratory chain function and content in Parkinson’s disease
Objective: We aimed to determine: 1) the feasibility of obtaining and characterising skeletal muscle; and 2) if muscle mitochondrial respiratory chain (MRC) function and content…Disease progression characterized by motor performance, dopaminergic neurodegeneration and T cell infiltration in the transgenic hm2-α-SYN-39 mouse model of Parkinson´s disease
Objective: To study disease progression in the transgenic (tg) hm2-α-SYN-39 mouse model of Parkinson´s disease (PD) by assessment of motor performance, dopaminergic neurodegeneration and T…Relationship between tumor and very slow Parkinson`s disease progression
Objective: We evaluate the Parkinson`s disease patients with very slow progression. One of their clinical features are the medical history of tumor. Background: Some cancer…
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 22
- Next Page »